This inventor holds 3 USPTO granted patents. Top assignees: Oxford Gene Systems Limited, British Biotech Pharmaceuticals Limited. Active years: 1991-1995.
Company Filing History:
Years Active: 1991-1995
Title: Michael H Malim: Innovator in Fusion Proteins and Particles
Introduction
Michael H Malim is a notable inventor based in Upleadon, GB. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins and particles. With a total of 3 patents to his name, Malim's work has implications for vaccines and diagnostic applications.
Latest Patents
Malim's latest patents focus on innovative fusion proteins and particles. The first patent describes fusion proteins that comprise a first amino acid sequence derived from a retrotransposon or an RNA retrovirus. This sequence allows the fusion protein to assemble into particles, with the TYA gene of the yeast retrotransposon Ty serving as an example. The second amino acid sequence is biologically active, potentially antigenic, making these particles useful in vaccines or diagnostic and purification applications. His second patent reiterates the importance of these fusion proteins, emphasizing their utility in similar applications.
Career Highlights
Throughout his career, Michael H Malim has worked with prominent companies in the biotechnology sector. He has been associated with Oxford Gene Systems Limited and British Biotech Pharmaceuticals Limited, where he has contributed to various innovative projects.
Collaborations
Malim has collaborated with notable individuals in his field, including Alan J Kingsman and Susan Mary Kingsman. Their collective efforts have further advanced the research and development of biotechnological innovations.
Conclusion
Michael H Malim's contributions to the field of fusion proteins and particles highlight his role as a significant inventor in biotechnology. His patents and collaborations reflect a commitment to advancing medical and diagnostic applications.